Next Article in Journal
1-(1H-Benzimidazol-2-yl)-3-[5-(trichloromethyl)-1,3,4-oxadiazol-2-yl]propan-1-one
Previous Article in Journal
(2E)-3-[4-(1H-Benzimidazol-2-ylmethoxy)-3-methoxyphenyl]-1-(4,4''-difluoro-5'-methoxy-1,1':3',1''-terphenyl-4'-yl)prop-2-en-1-one
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Short Note

2-Methoxy-5-{4-oxo-2-[(E)-2-(4-sulfamoylphenyl)ethenyl-3,4-dihydroquinazolin-3-yl]benzene-1-sulfonamide

1
Department of Pharmacy, Faculty of Natural Sciences, University of Indonesia, Depok, 16424, West Java, Indonesia
2
Research Center for Chemistry, Indonesian Institute of Sciences, Serpong, 15314, Indonesia
3
Department of Chemistry, Faculty of Natural Sciences, University of Indonesia, Depok, 16424, West Java, Indonesia
*
Author to whom correspondence should be addressed.
Molbank 2012, 2012(3), M765; https://doi.org/10.3390/M765
Submission received: 2 May 2012 / Accepted: 11 July 2012 / Published: 18 July 2012

Abstract

:
The title compound, 2-methoxy-5-{4-oxo-2-[(E)-2-(4-sulfamoylphenyl) ethenyl-3, 4-dihydroquinazolin-3-yl] benzene-1-sulfonamide 2 has been synthesized by the reaction of 3-(4-methoxyphenyl)-2-styryl-4(3H)-quinazolinone 1 with an excess of chlorosulfonic acid, followed by amidation of the sulfonyl chloride product with ammonia gas. The structure of the synthesized compound was confirmed on the basis of IR, 1H-NMR, 13C-NMR and mass spectral data.

Graphical Abstract

Compounds containing the 4(3H)-quinazolinone ring system possess various biological activities [1]. Some 4(3H)-quinazolinone derivatives have been synthesized and evaluated as potent and tolerable anti-inflammatory agents and are reported to exhibit significant COX-2 inhibition and anti-inflammatory activity [2,3]. The majority of COX-2 inhibitors are diarylheterocycles. The presence of para-sulfonamide or para-sulfonylmethane substituents at one of the phenyl rings was found to be essential for optimum COX-2 selectivity and inhibitory potency. A wide variety of heterocycles (five-membered or six-membered rings) can serve as central ring system of the diarylheterocyclic structures [4,5]. The results of a molecular docking study showed that a 2,3-disubsituted-4(3H)-quinazolinone possessing a p-benzenesulfonamide moiety at C-2 and a phenyl ring at N-3 was predicted to have potent COX-2 inhibitory activity [6]. The one-pot reaction sequence of chlorosulfonation-amidation was reported for the synthesis of sulfonamide-substituted diarylheterocycles, a class of selective COX-2 inhibitors [5,7]. In this paper, we report chlorosulfonation-amidation of 3-(4-methoxyphenyl)-2-styryl-4(3H)-quinazolinone 1.
The starting material 1 was prepared according to a reported method [1,8,9,10]. Compound 1 was reacted with an excess of chlorosulfonic acid at 0 °C to give a sulfonyl chloride product, then followed by treatment of the sulfonyl chloride with ammonia gas to produce 2-methoxy-5-{4-oxo-2-[(E)-2-(4-sulfamoylphenyl)ethenyl-3,4-dihydroquinazolin-3-yl]benzene-1-sulfonamide 2 (Scheme 1).
The IR spectrum of compound 2 showed absorption bands at 3373 and 3273 cm−1 due to the presence of NH2. The bands at 1335 and 1157 cm−1 correspond to -SO2-. In the 1H-NMR spectrum, four protons of two sulfonamide NH2 groups appear as two broad singlets at δ 7.29 and 7.40 ppm, while the four protons of the quinazolinone ring are observed as two triplets at δ 7.56 ppm (1H, J = 7.8 Hz, H-6) and δ 7.89 ppm (1H, J = 7.8 Hz, H-7), and two double doublets at δ 7.69 ppm (1H, J = 7.8, 2.6 Hz, H-8) and δ 8.l4 ppm (1H, J = 7.8, 1.3 Hz, H-5). Protons of the two phenyl rings appear at: δ 7.41 ppm (1H, d, J = 9.0 Hz, H-3'), δ 7.62 ppm (2H, d, J = 8.5 Hz, H-2"/6"), δ 7.78 ppm (3H, d, J = 8.3 Hz) and δ 7.82 ppm (1H, J = 2.15 Hz). The appearance of a proton of the phenyl ring as doublet at δ 7.82 ppm (1H, J = 2.15 Hz) indicates that the –SO2NH2 group subtituted an H of the phenyl ring at ortho position from the proton and methoxy group. The three protons of the phenyl ring observed as doublet at δ 7.78 ppm (J = 8.3 Hz) were described as overlapping of H-4' and H-3"/5". The appearance of the four protons as two doublets at δ 7.62 ppm (2H, J = 8.5 Hz, H-2"/6") and δ 7.78 ppm (2H, J = 8.3 Hz, H-3"/5") in the 1H-NMR spectrum and two pairs of symmetrical carbon atoms at δ 128.1 and δ 126.4 ppm in the 13C-NMR spectrum indicated that the second –SO2NH2 group subtituted a H at para position of the phenyl ring attached to the ethenyl chain. The structure is further supported by the HRESIMS of compound 2 which shows the molecular ion peak at m/z 513.0894 ([M+H]+). This value is in complete agreement with the structure assigned.

Experimental

Chlorosulfonic acid (2 mL, 16 mmol) was added dropwise to 1 (1.0 g, 3.2 mmol) at 0 °C with vigorous stirring under anhydrous conditions. The cooling bath was removed and the reaction was allowed to proceed for 6 h at 25 °C. The cooled reaction mixture was poured slowly onto crushed ice and the benzenesulfonyl chloride intermediate product was isolated by rapid filtration to reduce the exposure time to moisture. This product was dissolved in tetrahydrofuran (THF) (60 mL), and then gaseous ammonia was bubbled through the solution for 10 min at 25 °C. The solvent was removed in vacuo to give a residue, that was suspended in hot water. The hot suspension was filtered and the solid was recrystallized from acetonitrile. The crystals obtained were washed with cold ethanol (95%) and dried in a vacuum oven at 80 °C for 24 h.
Yield: 17%, m.p. 284–285 °C, pale yellow crystalline powder.
IR (KBr), υmax cm−1: 3381, 3235 (primary sulfonamide N-H streching), 3069 (aromatic/alkene C-H streching), 2945 (alkyl C-H streching), 1663 (C = O lactam), 1607 (C = N), 1550 (C = C), 1270 (aryl alkyl ether, Ar-O-C), 1338 and 1161 (sulfonamide asymetric and symetric SO2 streching) [11].
1H-NMR (500 MHz, DMSO-d6, TMS), δ/ppm: 8.14 (1H, dd, J = 7.8, 1.3 Hz, 5-Hquinazolinone), 7.93 (1H, d, J = 15.6 Hz, 2-Htrans-ethenyl), 7.89 (1H, t, J = 7.8 Hz, 7-Hquinazolinone), 7.82 (1H, d, J = 2.15 Hz, 6'-HPhe-X), 7.78 (3H, d, J = 8.3 Hz, overlapping of 3",5"-HPhe-Y and 4'-HPhe-X), 7.69 (1H, dd, J = 7.8, 2.6 Hz, 8-Hquinazolinone), 7.62 (2H, d, J = 8.2 Hz, 2",6"-HPhe-Y), 7.56 (1H, t, J = 7.8 Hz, 6-Hquinazolinone), 7.41 (1H, d, J = 9 Hz, 3'-HPhe-X), 7.4 (2H, s, broad, NH2sulfonamide), 7.29 (2H, s, broad, NH2sulfonamide), 6.5 (1H, d, J = 15.6 Hz, 1-Htrans-ethenyl), 4.01 (3H, s, OCH3) [11]. Phe-X = 2'-OMe-benzene-1'-sulfonamide. Phe-Y = 4"-sulfamoyl-phenylethenyl.
13C-NMR (125 MHz, DMSO-d6, TMS), δ/ppm: 161.5 (C(= O)-N, C-4quinazolinone), 156.3 (-N-C = N-, C-2quinazolinone), 151.2 (CPhe-O), 147.3 (CPhe-N=C, C-9quinazolinone), 144.6 (C-4"Phe-4"-sulfonamide), 128.1 (C-2",6"Phe-4"-sulfonamide), 126.4 (C-3",5"Phe-4"-sulfonamide), 56.6, (OCH3) 138.0 , 137.4, 134.3, 131.9,113.7, 134.9, 128.4, 128.3, 127.4, 126.9, 126.5, 122.5, and 120.8 (C aromatic and C ethenyl) [11].
HRESIMS (m/z): found 513.0894 ([M+H]+), calculated masses of C23H20N4O6S2: 513.0903 (error 1.8 ppm) (ACS acceptable limits error for HRMS is 5 ppm). The mass spectrum was measured with a Waters LCT Premier XE (ESI-TOF) on positive mode.

Supplementary materials

Supplementary File 1Supplementary File 2Supplementary File 3

Acknowledgments

We thank Endang Saefuddin, Yana Maolana Syah for helpful comments and suggestions, and the Directorate of Research and Community Services, University of Indonesia, Depok, Indonesia, for the financial support of this research. The authors are also thankful to Research Center for Chemistry of the Indonesian Institute of Sciences, Serpong, Indonesia and to Chemistry Study Program, Faculty of Natural Sciences, Bandung Institute of Technology (ITB), Bandung, Indonesia, for recording spectral data, and to the Directorate of Higher Education of the Ministry of Education and Culture of the Republic of Indonesia, for a doctoral fellowship (to Hayun).

References

  1. Connolly, D.J.; Cusack, D.; O’Sulivan, T.P.; Guiry, P.J. Synthesis of quinazolinones and quinazolines. Tetrahedron 2005, 61, 10153–10202. [Google Scholar] [CrossRef]
  2. Mohamed, M.S.; Kamel, M.M.; Abotaleb, N.; Nofal, S.M.; Ahmed, M.F. Novel 3-(p-Substituted-phenyl)-6-bromo-4(3H)-quinazolinone derivatives of promising anti-inflammatory and analgesic properties. Acta Pol. Pharm. Drug Res. 2009, 67, 487–500. [Google Scholar]
  3. Hitkari, A.; Bhalla, M.; Saxena, A.K.; Verma, M.; Gupta, M.P.; Shanker, K. Substituted quinazolinones and their anti-inflammatory activity. Boll. Chim. Farm. 1995, 134, 609–615. [Google Scholar] [PubMed]
  4. Kurumbail, R.G.; Stevens, A.M.; Gierse, J.K.; McDonald, J.J.; Stegeman, R.A.; Pak, J.Y.; Gildehaus, D.; Miyashiro, J.M.; Pening, T.D.; Seibert, K.; et al. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents. Nature 1996, 384, 644–648. [Google Scholar] [CrossRef] [PubMed]
  5. Uddin, M.J.; Rao, P.N.P.; Knaus, E.E. Design and synthetis of novel celecoxib analogues as selective cyclooxygenase-2 (COX-2) inhibitors: Replacement of sulfonamido pharmacophore by a sulfonylazide bioisostere. Bioorg. Med. Chem. 2003, 11, 5273–5280. [Google Scholar] [CrossRef]
  6. Hayun; Yanuar, A.; Hanafi, M.; Hudiyono, S. Virtual screening of 2,3-disubstituted-4(3H)-quinazolinones possessing benzenesulfonamide moiety for COX-2 inhibitor. Bioinformation 2011, 7, 246–250. [Google Scholar] [CrossRef] [PubMed]
  7. Carter, J.S.; Kramer, S.; Talley, J.J.; Penning, T.; Collins, P.; Graneto, M.J.; Seibert, K.; Koboldt, C.M.; Masferrer, J.; Zweifel, B. Synthesis and activity of sulfonamide-substituted 4,5-Diaryl thiazoles as selective cyclooxygenase-2 inhibitors. Bioorg. Med. Chem. Lett. 1999, 9, 1171–1174. [Google Scholar] [CrossRef]
  8. Errede, L.A. Acylanthranils.1. The pathway of quinazolinone formation in the reaction of acylanthranils with anilines. J. Org. Chem. 1976, 41, 1763–1765. [Google Scholar]
  9. Varma, R.S.; Bahadur, S.; Agnihotri, A.K. Synthesis of some 6-bromo-3-[(arylamino)methyl]- and 2-styryl-3-[4'-(carboalkoxy)phenyl]-4(3H)-quinazolinones. J. Chem. Eng. Data 1981, 26, 103–104. [Google Scholar] [CrossRef]
  10. Gupta, V.; Kashaw, S.K.; Jatav, V.; Mishra, P. Synthesis and antimicrobial activity of some new 3-[5-(4-substituted)phenyl-1,3,4-oxadiazole-2-yl]-2-styrylquinazoline-4(3H)-ones. Med. Chem. Res. 2008, 17, 205–211. [Google Scholar] [CrossRef]
  11. Silverstein, R.M.; Webster, F.X.; Kiemle, D.J. Spectrometric Identification of Organic Compounds, 7th ed.; John Wiley & Sons, Inc.: New York, NY, USA, 2005. [Google Scholar]
Scheme 1.  
Scheme 1.  
Molbank 2012 m765 sch001

Share and Cite

MDPI and ACS Style

Hayun; Hanafi, M.; Yanuar, A.; Hudiyono, S. 2-Methoxy-5-{4-oxo-2-[(E)-2-(4-sulfamoylphenyl)ethenyl-3,4-dihydroquinazolin-3-yl]benzene-1-sulfonamide. Molbank 2012, 2012, M765. https://doi.org/10.3390/M765

AMA Style

Hayun, Hanafi M, Yanuar A, Hudiyono S. 2-Methoxy-5-{4-oxo-2-[(E)-2-(4-sulfamoylphenyl)ethenyl-3,4-dihydroquinazolin-3-yl]benzene-1-sulfonamide. Molbank. 2012; 2012(3):M765. https://doi.org/10.3390/M765

Chicago/Turabian Style

Hayun, Muhammad Hanafi, Arry Yanuar, and Sumi Hudiyono. 2012. "2-Methoxy-5-{4-oxo-2-[(E)-2-(4-sulfamoylphenyl)ethenyl-3,4-dihydroquinazolin-3-yl]benzene-1-sulfonamide" Molbank 2012, no. 3: M765. https://doi.org/10.3390/M765

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop